Ghazarian L, Simoni Y, Magalhaes I, Lehuen A.Invariant NKT cell development: focus on NOD mice [J].Curr Opin Immunol,2014,2(4):83-88.
[2]
Godfrey DI,MacDonald HR,Kronenberg M,et al. NKT cells：what’s in a name? [J]Nat Rev Immunol,2004,4(3):231-237.
[3]
Bendelac, A,Savage, P.B, Teyton, L. The biology of NKT cells [J]. Annu. Rev. Immunol,2007, 25(4):297-336.
[4]
Gapin, L,Godfrey, D.I, Rossjohn, J. Natural killer T cell obsession with self-antigens [J]. Curr. Opin. Immunol2013, 25(2):168-173.
[5]
Pellicci,D.G,Patel.O,Kjer-Nielsen.L.et al. Differential recognition of CD1d-alpha- -galactosyl ceramide by the v beta 8.2 and v beta 7 semi-invariant NKT T cell receptors [J]. Immunity,2009, 31(1):47-59.
[6]
Ambrosino, E,Terabe, M, Halder, R.C,et al., Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis [J].J. Immunol,2007. 179(8): 5126-5136.
[7]
Roy,K.C,Maricic,I,Khurana,A,et al.Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells [J]. J. Immunol, 2008,180(5): 2942-2950.
[8]
Diao H, He J, Zheng Q,et al.A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment [J].Immunol Lett,2014(14)：00059.
Godfrey DI, Uldrich AP, Baxter AG. NKT cells an early warning system for HBV infection [J]. Nat Med,2012,18(7):1014-1016.
[13]
Cernadas, M, Cavallari, M, Watts, G, et al. Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens [J].J. Immunol,2010, 184(3):1235-1241.
[14]
Lawson, V. Turned on by danger: Activation of CD1d-restricted invariant natural killer T cells [J]. Immunology,2012, 137(1):20-27.
[15]
Zeissig S, Dougan SK, Barral DC, et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function [J]. J Clin Invest, 2010,120(8):2889-2899.
[16]
Zeissig S, Murata K, Sweet L et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity [J]. Nat Med, 2012 ,18(7):1060-8.
[17]
Brian L. Anderson , Luc Teyton , Albert Bendelac,et al. Stimulation of Natural Killer T Cells by Glycolipids [J].Molecules 2013,18(1)：15662-15688.
[18]
Kronenberg M, Matsuda J.L, Gapin L, et al. Mouse v alpha 14i natural killer T cells are resistant to cytokine polarization in vivo [J]. Proc. Natl. Acad. Sci. USA,2003,100(14):8395-8400.
[19]
Uldrich AP, Crowe NY, Kyparissoudis K,et al. NKT cell stimulation with glycolipid antigen in vivo :Costimulation-dependent expansion, bim-dependent contraction, and hypores- -ponsiveness to further antigenic challenge [J]. J. Immunol, 2005, 175(5):3092-3101.
[20]
Parekh V.V., Wilson M.T., Olivares-Villagomez, D.et al.Glycolipid antigen induces long- -term natural killer T cell anergy in mice [J].J. Clin. Invest, 2005, 115(9):2572-2583.
[21]
Wang H, Feng D, Park O et al.Invariant NKT cell activation induces neutrophil accumulation and hepatitis: Opposite regulation by IL-4 and IFN-γ [J].Hepatology, 2013,58(4):1074-1085.
[22]
Wang XF, Lei Y, Chen M et al. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication [J]. Journal of Viral Hepatitis, 2013,20(1):27-39.
[23]
Akbari O, Stock P, Singh AK, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions [J].Mucosal Immunol, 2010,3(1):81-91.
[24]
Borowski AB, Boesteanu AC, Mueller YM, et al. Memory CD8+ T cells require CD28 costimulation [J]. J Immunol,2007,179(10): 6494-6503.
[25]
Exley MA, He Q, Cheng O et al.Cutting edge: compartmentalization of Th1-like noninvariant CD1d- reactive T cells in hepatitis C virus-infected liver [J]. J Immunol, 2002,168(4):1519-1523.
[26]
Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide [J]. J Exp Med,2004,199(7):947-957.
